Delivery Order HT942525DE004-HT942726FE009
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,760.12 to AmerisourceBergen Drug Corp for Octagam 10% Vial 300ML, a pharmaceutical product supporting federal medical procurement needs. The award, issued on October 17, 2025, with an ultimate completion date of November 7, 2025, represents a firm fixed-price, competitively awarded contract with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,477.68 to AmerisourceBergen Drug Corp for Octagam 10% Vial 200ML, a pharmaceutical product for federal medical procurement. This is a firm fixed price delivery order with an ultimate completion date of December 16, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal healthcare...
- The Defense Logistics Agency awarded a $2,583.74 delivery order to AmerisourceBergen Drug Corp for OCTAGAM 10% Vial 300ML, a pharmaceutical product for federal medical supply needs. This contract, issued on January 5, 2026, with an ultimate completion date of January 27, 2026, represents a firm fixed-price delivery order with no set-aside designation. The award was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $8,955.36 to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Octagam 10% Vial 200ML, an intravenous immunoglobulin product used for immune deficiency treatment. The contract is a firm fixed price delivery order with an ultimate completion date of January 15, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was not subject to any set-aside designation and was...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OCTAGAM 10% VIAL 300ML. The contract is a firm fixed-price delivery order with a ceiling value of $4,491.48 and an ultimate completion date of September 20, 2024. This order is likely part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December...
- The Defense Logistics Agency awarded a $4,477.68 delivery order to AmerisourceBergen Drug Corp for OCTAGAM 10% Vial 200ML, a pharmaceutical product, with performance in Conshohocken, Pennsylvania. The award, issued on December 3, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of December 24, 2025. This contract represents a non-competitive set-aside award and serves as a child order under AmerisourceBergen's larger federal contract vehicle. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $6,737.22 firm fixed price delivery order is for the supply of 300 mL vials of the immunoglobulin product OCTAGAM 10%. The award is associated with a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $5,512.84 firm fixed price delivery order is for the provision of OCTAGAM 10% VIAL 300ML, a pharmaceutical product, with a completion date of May 31, 2024. The contract is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
- The Defense Health Agency awarded a $31,779.07 firm fixed-price Blanket Purchase Agreement (BPA) call to Drk-Blutspendedienst Rheinland-Pfalz und Saarland Gemeinnützige Gesellschaft mit beschränkter Haftung on October 1, 2025, for the supply of blood and blood products. The performance location is Germany, with completion scheduled for December 31, 2025. This contract was awarded without a set-aside designation through full and open competition. The prime contractor, doing business as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Hemlibra 105 mg/0.7 mL vials, a specialty pharmaceutical product used in hemophilia treatment. This competitively awarded, firm fixed-price delivery order has a ceiling value of $6,168.26 and is scheduled for completion by November 10, 2025. The contract is not set-aside and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- HT942525DE004Indefinite Delivery Contract
- HT942525DE004-HT942726FE009Delivery Order
The Defense Health Agency awarded a $1.92M delivery order to Octapharma USA Inc. on January 16, 2026, for the procurement and delivery of 1,600 units of Octaplas LG to Blood Bank West, with an ultimate completion date of May 29, 2026. Octaplas LG is a solvent/detergent-treated liquid plasma product critical for emergency medical treatment, particularly for addressing coagulopathies, hemorrhage control, and clotting factor restoration in military and federal healthcare settings. The contract utilizes a firm fixed-price structure with no small business set-aside designation and represents performance at the contractor's facility in Paramus, New Jersey. This delivery order is issued under Octapharma USA Inc.'s single-award Indefinite Delivery Contract with the Defense Health Agency, valued at $14.88M with a completion date of September 14, 2030. The master contract, awarded September 15, 2025, encompasses the supply of Octaplas LG powder under Food and Drug Administration Emergency Use Authorization, along with ancillary medical supplies including sterile water for injection, transfusion sets with filters, transfer sets, alcohol swabs, and vented spike adapters. As a foreign-owned pharmaceutical manufacturer specializing in blood plasma products, Octapharma has been registered as a federal contractor since 2005 and provides essential medical supplies supporting military medical readiness and operational medicine capabilities across the military health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9m | 1/14/26 |